UPM Research Ethics Board

We have updated the information under the following tabs:
1. Common Issues in Registration
2. FAQs
3. Process of Submission

UPMREB attended the 20TH INTERNATIONAL CONFERENCE of the Forum for Ethical Review Committees in Asia and the Western Pacific (FERCAP) held last December 7-9, 2020 via Zoom, in collaboration with the National Institutes of Health - University of the Philippines Manila (NIH-UPM) in partnership with the Philippine Health Research Ethics Network (PHREN). The them of the conference is “Addressing Ethical Challenges During the COVID-19 Outbreak”.

You can watch this short video made by our UPMREB Chair, Dr. Jacinto Blas V. Mantaring III, to guide you in navigating iREB and making your first initial submission for ethics review: https://www.youtube.com/watch?v=3UT2HhkJ-ZU

Please be advised of the following cut-off dates for all 2020 submissions to all UPMREB Review Panels, in view of the forthcoming Christmas break:
 8 December 2020 for the last day of screening applications
 9 December 2020 for the last day of receiving submissions

Please be informed of the updated Guideline on Reporting Serious Adverse Events of the UP Manila Research Ethics Board (UPMREB) approved on 03 July 2020, GL 02 Version 2.0. This document is downloadable at this website: http://reb.upm.edu.ph.

Please be advised that UPMREB is reinstating the requirement of signed endorsements of the UPMREB Form 2B: Registration and Application Form, starting 10 August 2020. See attached memo for reference.

To apply for ethical review, please register for an account and submit through https://ireb.upm.edu.ph.

For subsequent submissions (e.g. resubmission, amendment, continuing review, final report, deviation, query/notification, etc), please email your submission with the necessary documents to upmreb@post.upm.edu.ph using the following subject heading: "Type of submission_PI Last Name_UPMREB Code".

FDA and PHREB has released some guidance for COVID-19 protocols.

1. PHREB Resolution No. 2020-001 on COVID-19 Research proposals
2. FDA Circular No. 2020-013 on Guidelines for monitoring drug-products used for the treatment of COVID-19

The UP Manila Research Ethics Board (UPMREB) reiterates its previous announcement of normal operations during the enhanced community quarantine. The UPMREB physical office is closed but the review panels will continue to accept and process submissions, queries, and other requests through iREB and email. The requirement for hard copy submissions is suspended until such time that the UPMREB office reopens, after quarantine has been lifted. All reviews are facilitated online, and panel actions are communicated to investigators through electronic mail. Standard review turnaround time remains.

UPMREB will be adopting work from home arrangement in light of the covid-19 situation, detailed as follows:
1. Processing of submissions via iREB and electronic mail
a. Once verified complete, study protocol application will be coded and assigned into a panel
b. Staff will acknowledge receipt of study protocol through e-mail
c. Received submissions will be forwarded to the reviewers electronically

2. Facilitation of reviews via iREB and electronic mail